Hong Kong — 20 November 2024 — Genèse Labs is pleased to announce that Proluma™, its next-generation PDLLA collagen stimulator, has won in the “Best Aesthetic Product” category at Cosmoprof Asia 2024 in Hong Kong.

The award recognises Proluma™ as a leading product within the regenerative aesthetics category. Since its global launch, Proluma™ has rapidly built recognition among dermatologists, aesthetic physicians and distributors for its ability to deliver natural, long-lasting facial rejuvenation through controlled collagen stimulation. The core strengths reflected in the award include precision-engineered PDLLA microspheres based on proprietary polymer technology developed at the French headquarters, smooth tissue integration with predictable performance and ease of use, growing adoption across Europe, Asia, the Middle East and Latin America, and strong feedback from practitioners seeking an alternative to conventional volumising fillers.

The “Best Aesthetic Product” category at Cosmoprof Asia evaluates innovation, safety profile, scientific formulation and overall clinical suitability. The award for Proluma™ highlights the substantive value the product contributes to aesthetic medicine and its potential to become a reference point in the regenerative segment. Its regulatory record — a Class III medical device holding CE 1434 certification, using PLA recognised by the US FDA as a medical-device material, and completing KFDA registration in Korea — served as objective evidence of safety and quality during the judging process.

This recognition came during a period of rapid expansion for Genèse Labs, following the successive launches of RG60®, Citrus Bottle™ and Exoluma™. The award for Proluma™ reinforces the company’s long-term strategy of developing high-performance, scientifically grounded aesthetic solutions supported by global visibility and clinical credibility.

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across the fast-growing fields of body contouring, collagen biostimulation, and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including RG60®, Proluma™, Citrus Bottle™ and the Exoluma™ series — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians, and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.